THE SCIENCE : 정신분열증 재발률 낮추는 신약후보물질 개발
THE SCIENCE : 정신분열증 재발률 낮추는 신약후보물질 개발: 박우규 박사는 “이번에 개발한 기술은 기존에 나온 치료제들과 달리 정신질환을 일으키는 근본 원인에 대해 선택적으로 작용한다는 점에서 독창성과 차별성이 있다” ...
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.